- Tytuł:
- Venetoclax or placebo in combination with bortezomib and dexamethasone in patients with relapsed or refractory multiple myeloma (BELLINI): a randomised, double-blind, multicentre, phase 3 trial
- Autorzy:
- Źródło:
- In The Lancet Oncology December 2020 21(12):1630-1642
Czasopismo naukowe